NYXOID 1.8 mg, solution as a nasal spray in a single-dose container 2 bottles of 0.1 ml
Active ingredients: Naloxone hydrochloride dihydrate, Naloxone
Commercialized according to BDPMDispensing in France: Prescription only
Solution for spraying2 bottles of 0.1 mlnasale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NYXOID 1,8 mg, solution pour pulvérisation nasale en récipient unidose
- Pharmaceutical form
- solution pour pulvérisation
- Route of administration
- nasale
- Presentation description
- 2 flacons pulvérisateurs nasaux en récipient unidose de 0,1 mL
- Marketing authorisation holder
- MUNDIPHARMA CORPORATION (IRELAND)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 20 Sept 2021
- Prescription and dispensing conditions
- Prescription onlyOriginal BDPM wording: médicament soumis à prescription médicale
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63868145CIP73018139CIP133400930181393Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| NALOXONEsolution | 1,8 mg · une dose | FT |
| CHLORHYDRATE DE NALOXONE DIHYDRATÉsolution | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.